PITTSBURGH, Aug. 6, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its business Mylan Institutional has received final approval from the U.S. Food and Drug Administration (FDA) for ...
Studies suggest this peptide is an analog of Selank, a possibly powerful peptide with nootropic and anxiety-reducing potential. Researchers anticipate the following properties from the proposed ...
Mylan announced the launch of Etomidate Injection 2mg/mL, the generic version of Hospira‘s Amidate Injection. Etomidate Injection is an intravenous hypnotic agent indicated for the induction of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback